Abstract
The goal of functional genomics is to understand the relationship between whole genomes and phenotypes through a dynamic approach. It requires high throughput technologies such as microarrays and data analysis. The power of this approach allowed to study complex biological functions as well as diseases. In this chapter, we introduce functional genomics and describe the statistical methods that are used to find differentially expressed genes. We analyze a large number of data sets produced on a complex disease, namely Down syndrome, in different models. We show that, whatever the model, genes that are in three copies are globally overexpressed. However, we failed to identify a set of two-copy genes that would be dysregulated in all studies. It either suggests that studies are incomplete, or that this set of genes does not exist and that overexpression of the three-copy genes impacts on the whole transcriptome in a “stochastic” way.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
Transforming expression data to a log scale (any base) reduces the asymmetry of the distribution of the intensities and homogenizes their variance. Here, probe intensities are systematically log2values.
References
Ait Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, Golfier G et al. (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 81(3):475–491
Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N et al. (2004) Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum Mol Genet 13(13):1333–1340
Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5(10):725–738
Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9(2):195–202
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57(1):289–300
Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101(7):2173–2178
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2):185–193
Bontoux N, Dauphinot L, Vitalis T, Studer V, Chen Y, Rossier J et al. (2008) Integrating whole transcriptome assays on a lab-on-a-chip for single cell gene profiling. Lab Chip 8(3):443–450
Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829–836
Dauphinot L, Lyle R, Rivals I, Dang MT, Moldrich RX, Golfier G et al. (2005) The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum Mol Genet 14(3):373–384
Dudoit S, Yang YH, Callow MJ, Speed T (2002) Statistical methods for identifying genes with differential expression in replicated cDNA microarray experiments. Stat Sin 12:111–139
Dunlop MJ, Cox RS 3rd, Levine JH, Murray RM, Elowitz MB (2008) Regulatory activity revealed by dynamic correlations in gene expression noise. Nat Genet 40(12):1493–1498
Emilsson L, Saetre P, Jazin E (2006) Alzheimer’s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis 21(3): 618–625
Epstein CJ (1990) The consequences of chromosome imbalance. Am J Med Genet 7(Suppl):31–37
FitzPatrick DR, Ramsay J, McGill NI, Shade M, Carothers AD, Hastie ND (2002) Transcriptome analysis of human autosomal trisomy. Hum Mol Genet 11(26):3249–3256
Giannone S, Strippoli P, Vitale L, Casadei R, Canaider S, Lenzi L et al. (2004) Gene expression profile analysis in human T lymphocytes from patients with Down syndrome. Ann Hum Genet 68(Pt 6):546–554
Golfier G, Lemoine S, van Miltenberg A, Bendjoudi A, Rossier J, Le Crom S et al. (2009) Selection of oligonucleotides for whole-genome microarrays with semi-automatic update. Bioinformatics 25(1):128–129
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093
Johnson RA, Wichern DW (2002) Applied multivariate statistical analysis. Prentice-Hall, Upper Saddle River
Laffaire J, Rivals I, Dauphinot L, Pasteau F, Wehrle R, Larrat B et al. (2009) Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genom 10:138
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099
Lejeune J, Gautier M, Turpin R (1959) Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 248(11):1721–1722
Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S (2007) Gene expression profiling in the adult Down syndrome brain. Genomics 90(6):647–660
Losick R, Desplan C (2008) Stochasticity and cell fate. Science 320(5872):65–68
Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J et al. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429(6994):883–891
Maamar H, Raj A, Dubnau D (2007) Noise in gene expression determines cell fate in Bacillus subtilis. Science 317(5837):526–529
Macarthur BD, Ma’ayan A, Lemischka IR (2009) Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 10(10):672–681
Maes OC, Xu S, Yu B, Chertkow HM, Wang E, Schipper HM (2007) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28(12):1795–1809
Mao R, Zielke CL, Zielke HR, Pevsner J (2003) Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81(5):457–467
Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H et al. (2005) Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol 6(13):R107
McLachlan GJ, Do K-A, Ambroise C (2004) Analyzing microarray gene expression data. Wiley, New York
Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of transcriptional changes in Alzheimer’s disease and normal aging. J Neurosci 28(6):1410–1420
Moldrich RX, Dauphinot L, Laffaire J, Vitalis T, Herault Y, Beart PM et al. (2009) Proliferation deficits and gene expression dysregulation in Down’s syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres. J Neurosci Res 87(14):3143–3152
Nagasaka Y, Dillner K, Ebise H, Teramoto R, Nakagawa H, Lilius L et al. (2005) A unique gene expression signature discriminates familial Alzheimer’s disease mutation carriers from their wild-type siblings. Proc Natl Acad Sci U S A 102(41):14854–14859
Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH (2004) Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230(3):581–589
Potier MC, Rivals I, Mercier G, Ettwiller L, Moldrich RX, Laffaire J et al. (2006) Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development. J Neurochem 97(Suppl 1):104–109
Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M et al. (2007) Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 81(2):252–263
Ray M, Ruan J, Zhang W (2008) Variations in the transcriptome of Alzheimer’s disease reveal molecular networks involved in cardiovascular diseases. Genome Biol 9(10):R148
Rivals I, Personnaz L, Taing L, Potier MC (2007) Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics 23(4):401–407
Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH (2006) Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci U S A 103(5):1452–1456
Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT et al. (2000) Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48(5):606–613
Saran NG, Pletcher MT, Natale JE, Cheng Y, Reeves RH (2003) Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet 12(16): 2013–2019
Sartor MA, Leikauf GD, Medvedovic M (2009) LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data. Bioinformatics 25(2):211–217
Sasik R, Woelk CH, Corbeil J (2004) Microarray truths and consequences. J Mol Endocrinol 33:1–9
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235):467–470
Singh A, Weinberger LS (2009) Stochastic gene expression as a molecular switch for viral latency. Curr Opin Microbiol 4:460–466. http://www.doodle.com/yix62vkik5gks8v612
Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z et al. (2009) Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 106(23):9425–9429
Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100(16):9440–9445
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550
Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98(9):5116–5121
Vencio RZ, Shmulevich I (2007) ProbCD: enrichment analysis accounting for categorization uncertainty. BMC Bioinforma 8:383
Westfall PH, Young SS (1992) Resampling-based multiple testing. Wiley, New York
Acknowledgements
The authors wish to thank The European program AnEUploidy and the Fondation Jérôme Lejeune for their financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Potier, MC., Rivals, I. (2012). Functional Genomics and Molecular Networks Gene Expression Regulations in Complex Diseases: Down Syndrome as a Case Study. In: Le Novère, N. (eds) Computational Systems Neurobiology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3858-4_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-3858-4_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-3857-7
Online ISBN: 978-94-007-3858-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)